Peishan Hu

Prof. Peishan Hu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
FLFurong Liu
Furong Liu
XWXiaoli Wei
Xiaoli Wei
ZCZhanhong Chen
Zhanhong Chen
YCYanxing Chen
Yanxing Chen
PHPeishan Hu
Peishan Hu
YJYING JIN
YING JIN

30 January 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CCChong Chen
Chong Chen
DCDu Cai
Du Cai
XLXuanhui Liu
Xuanhui Liu
YZYifan Zheng
Yifan Zheng
XHXinxin Huang
Xinxin Huang
PHPeishan Hu
Peishan Hu
The acidic tumor microenvironment provides the energy that drives the development of malignant tumors. High concentrations of lactic acid and H + are key features of the acidic tumor microenvironment, and lactylation has gradually been shown to play a significant role in tumor progression. The expression of solute carrier family 26 member 3 (SLC26A3) is closely related to the occurrence and development of colorectal cancer (CRC), but the specific molecular mechanisms remain unclear. We demonstrated that alterations in the acidic microenvironment and overexpression of SLC26A3 significantly inhibited CRC occurrence and progression in vivo. Our study indicates that SLC26A3 undergoes lactylation in the acidic tumor microenvironment, which decreases SLC26A3 stability and expression. SLC26A3 interacts with the RNA-binding proteins Hu antigen R (HuR) and CUG-binding protein 1 (CUGBP1). When SLC26A3 expression is reduced, its ability to bind to HuR/CUGBP1 is weakened. As a result, HuR and CUGBP1 more readily interact with a subset of oncogenic mRNAs, regulating their stability and influencing their expression, ultimately promoting malignant tumor progression. These findings highlight the role of SLC26A3 as a potential suppressor of CRC recurrence, drug resistance, and metastasis, providing new insights for improving the clinical treatment and prognosis of CRC.

6 August 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Open access
TLTing Li
Ting Li
YBYi-Ran Bie
Yi-Ran Bie
SCShan-Mei Chen
Shan-Mei Chen
YSYao Shang
Yao Shang
PHPeishan Hu
Peishan Hu
Fatty acids (FA) are essential macromolecules in living organisms and play critical roles in processes such as cancer development, inflammation, and autoimmunity. Immune responses and metabolic changes are involved in tumor occurrence, development, invasion, and metastasis, and therapies targeting immunity and metabolism have gradually begun to be developed in clinical practice. Recent studies have revealed alterations in fatty acid metabolism in tumor microenvironment, suggesting that the modulation of fatty acid metabolism can affect the efficacy of immunotherapy. In this review, we summarize the effects of fatty acids on cancer immunotherapy in aspects including tumor cell metabolism, protein lipid modification, and clinical applications. A deeper understanding of the mechanisms by which FA and their metabolites participate in immune response can enhance our knowledge of their function in tumor development and their impact on the immune system, thereby providing new strategies for improving cancer immunotherapy.

11 March 2026 in Cancer Letters
Verified
Journal Article
Open access
CHChuling Hu
Chuling Hu
DCDu Cai
Du Cai
WYWeiqiang You
Weiqiang You
ZZZhengran Zhou
Zhengran Zhou
JLJunwei Liu
Junwei Liu
FGFeng Gao
Feng Gao
The heterogeneity of tumor immune microenvironment accounts for differential prognosis and immunotherapy responsiveness among colorectal cancer (CRC) patients. Here, we developed a novel immune classification for colorectal cancer through integrative multi-omics analysis. Immune-related gene expression, mutation, and methylation profiles were collected from two large-scale multi-omics CRC cohort (TCGA, n = 627; COCC, n = 977) to perform multi-omics factor analysis (MOFA) and establish the Multi-Omics Tumor Immune Features-based Clusters of CRC (MotifCC). The molecular differences and tumor immune variations among different clusters were analyzed and experimentally validated. Potential molecular targets for converting immune-cold tumors into hot tumors were validated with cell lines, patient-derived organoids (PDOs), and animal models. Integrative multi-omics analysis revealed three novel clusters with distinct characteristics. Cluster1, with high WNT pathway activation, had the worst prognosis and a tumor-promoting microenvironment. This immune-cold subtype may benefit from a combination of immunotherapy and WNT-targeted treatment. Cluster2 was characterized by low immune infiltration and high glycolysis intensity. These patients may benefit from treatment with metabolism inhibitors. Cluster3 was distinguished by high gene methylation, high tumor mutation burden, microsatellite instability, and better response towards immunotherapy. We successfully established the MotifCC, a novel multi-omics immune classification system for CRC. This system effectively captures the multi-omics heterogeneity of CRC, providing valuable insights for tailoring immunotherapy strategies and potentially improving patient outcomes.

30 June 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
XHXinxin Huang
Xinxin Huang
XHXinxin Huang
Xinxin Huang
ZLZekun Liu
Zekun Liu
YWYihang Wu
Yihang Wu
XLXiaotong Luo
Xiaotong Luo
PHPeishan Hu
Peishan Hu
Background: Duodenal adenocarcinoma (DA) is often insidious due to the low rate of early diagnosis and because the mechanisms that underlie its malignant progression are poorly understood. The tumor microenvironment (TME) plays a crucial regulatory role in promoting tumor malignancy. Hence, this study aimed to identify novel biomarkers for early diagnosis and potential therapeutic targets for DA. Methods: Surgical resection samples and normal tissues from DA patients were collected for RNA sequencing (RNA-seq). The characteristics of TME in DA patients were analyzed, and the differentially expressed long non-coding RNAs (lncRNA) were screened. Functional experiments were performed to verify the relationship between Linc01559, G-rich sequence binding factor 1 (GRSF1), and tumor malignant phenotype. Results: The present study revealed that DA exhibits a significantly upregulated expression of acidic environment markers and a high degree of macrophage infiltration. Further investigation revealed that macrophages upregulate the expression of the long noncoding RNA, Linc01559, in DA through the STAT3/c-MYC signaling pathway, thereby promoting malignant phenotypes such as invasion, metastasis, tumor stemness, and apoptosis. The interaction between GRSF1 and Linc01559 was subsequently confirmed using RNA pulldown-mass spectrometry. It was further revealed that Linc01559 promotes the malignant phenotype of duodenal cancer cells through its interaction with GRSF1. Conclusions: These findings demonstrate that the acidic microenvironment influences the phenotype of DA by regulating the Linc01559–GRSF1 axis. Therefore, these findings provide potential targets for the early detection and treatment of DA.